Targeting CD44 in mast cell regulation

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.1, 2010-01, pp. : 31-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of CD44 in tumour progression and strategies for targeting

By Negi Lalit Mohan Talegaonkar Sushama Jaggi Manu Ahmad Farhan J. Iqbal Zeenat Khar Roop K.

Journal of Drug Targeting, Vol. 20, Iss. 7, 2012-08 ,pp. : 561-573

Informa Healthcare

Access to resources Recommend Favorite

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell

By Leonardi Andrea Quintieri Luigi

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 969-981

Informa Healthcare

Access to resources Recommend Favorite

Regulation of Mast Cell Development by Inflammatory Factors

Current Medicinal Chemistry, Vol. 14, Iss. 28, 2007-12 ,pp. : 3044-3050

Bentham Science Publishers

Access to resources Recommend Favorite

PIP3 Regulation as Promising Targeted Therapy of Mast-Cell-Mediated Diseases

Current Pharmaceutical Design, Vol. 17, Iss. 34, 2011-11 ,pp. : 3815-3822

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting mast cells

By Norris Alan

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 7, 2004-07 ,pp. : 739-741

Informa Healthcare

Access to resources Recommend Favorite